Parkway Shenton in Singapore is the first primary healthcare facility in Asia Pacific to offer digital brain screening and monitoring utilizing Neurowyzr's unique Digital Brain Function Scan. This can lead to earlier detection of brain health issues such as cognitive decline, stroke, Long Covid brain damage, Parkinson's disease, and dementia.
Neurowyzr, a Singapore Brain Capital business that uses neuroscience-based digital solutions, has established a collaboration with Parkway Shenton to provide digital brain health screening and monitoring tools.
Singaporeans now have access to a computerized neuroscience instrument that can identify cognitive impairment early. After being prescribed by a physician, it is quick, inexpensive, and available through an internet gateway. The medical-grade Digital Brain Function Scan from Neurowyzr may be linked to a device (such as a smartphone, iPad, laptop, or PC) and a browser to complete an evaluation in minutes. This lowers the need for many doctor visits and costs to understand brain health.
Brain cognitive screening is recommended for all individuals as part of routine healthcare screening by the World Health Organization and renowned clinical neuroscientists. According to neuroscience research, over 10% of persons over the age of 30 have a brain health concern known as Mild Cognitive Impairment (MCI). The proportion rises to 25% among persons aged 50, and 40% among those aged 60.
People who have undiagnosed, untreated, or poorly managed chronic Noncommunicable Diseases (NCDs) such as hypertension, diabetes, obesity, metabolic syndrome, and high cholesterol and high lipids are more likely to develop MCI. Those who seem healthy but have early liver, kidney, lung, or cardiac failure or malfunction are also included. This digital brain health screening becomes a significant general health test for a thorough examination of brain and body health.
Source: Biospectrumasia
Comments